Adjunctive cannabidiol improved multiple TSC-associated neuropsychiatric symptoms, including irritability, in a phase 3b/4 study described by investigators as the first to assess these outcomes.
France will ban the sale of cannabidiol (CBD) edibles from May 15, while still allowing it to be sold to be smoked, AFP ...
Anxiety, psychosis and paranoia are among adverse events people are reporting after using higher-strength medicinal cannabis, ...
The latest health news includes a call by former President Trump for Congress to update laws to ensure access to CBD products, global medical concerns like bird flu leading to import bans, innovations ...
Executive Orders and Policy Updates - In the end of 2025 and the first quarter of 2026, the Trump administration and federal ...
U.S. ⁠President Donald ​Trump ‌in ‌a ⁠Truth Social ⁠post on Thursday ​called ​on ⁠Congress ⁠to ⁠update the law ​to ​ensure ⁠that ⁠Americans can access "full-spectrum" cannabidiol (CBD) ⁠products.
Long associated with the relief of certain symptoms, cannabidiol (CBD), which has no psychoactive effect, is generating ...
Devices announced it has completed the acquisition of NIRLAB AG, a Switzerland-based company specializing in handheld ...
The team developed a stretchy, hemp-derived thermoplastic that is capable of extending up to 1,600% of its size. Thanks to ...
The reclassification of cannabis as a Schedule III substance is meant to remove barriers for researchers but its effects ...
The government recently loosened medical marijuana rules. Experts separate fact from fiction about the drug’s safety and ...